Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

First-in-class TrxR inhibitor shows efficacy in an ovarian cancer mouse model

April 23, 2020

Tempest enrolling in phase Ia/Ib study of TPST-1495 for advanced solid tumors

April 22, 2020

FDA approves Imbruvica with rituximab for previously untreated CLL or SLL

April 22, 2020

Genentech and Roche present MAP4K1 inhibitors

April 22, 2020

Novel IL-27-based targeting gene therapy shows promise in prostate cancer models

April 22, 2020

IMDC recommends continuation of phase III trial of eryaspase in advanced pancreatic cancer

April 21, 2020

RAPT Therapeutics patents USP7 inhibitors

April 21, 2020

A paracrine interaction between breast cancer cells and MAFs promotes metastatic progression

April 21, 2020

Kazia updates findings from phase I study of Cantrixil in ovarian cancer

April 20, 2020

FDA approves Tukysa for advanced, unresectable or metastatic HER2-positive breast cancer

April 20, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...